Billionaire Profile
Stéphane Bancel
Global Rank
#2055

Image: Brenda Bancel | GFDL | via Wikimedia Commons

Stéphane Bancel

CEO, Biotech
FRANCE
Real-Time Net Worth
$2.038B
Estimated based on Biotech stock value as of April 20, 2026
0% (24h)
Age
53
Source
Biotech, vaccines
Industry
Healthcare
Citizenship
FRANCE

Biography

Stéphane Bancel is the CEO of Moderna, a leading biotechnology company focused on mRNA therapeutics, particularly vaccines. Born in Marseille, France, Bancel, at 53 years old, has a net worth of $2.0 billion, stemming from his expertise in biotech and vaccines. He earned an MBA from Harvard Business School and holds master's degrees from École Centrale Paris and the University of Minnesota. His career includes leadership roles at BioMérieux and Eli Lilly before joining Moderna in 2011. Bancel was nominated Chevalier of the Legion d'honneur in 2022 and was elected to the U.S. National Academy of Engineering in 2024.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Stéphane Bancel was born in Marseille, France. His father was an engineer, and his mother was a doctor. Bancel enjoyed science and mathematics during his childhood. He studied engineering at École Centrale Paris (CentraleSupélec) and biological engineering at the University of Minnesota, earning master's degrees at both institutions. He later earned an MBA from Harvard Business School.

Rise to Success

Bancel's career began at Eli Lilly and Company and bioMérieux SA, where he served as CEO. In 2011, he became the CEO of Moderna. Under his leadership, Moderna developed and commercialized the COVID-19 vaccine, which generated significant revenue and propelled the company to prominence.

Key Business Strategies

Bancel has focused on mRNA technology for developing drugs and vaccines. He has expanded the company's research into oncology, cardiovascular disease, and rare genetic diseases. Bancel has also emphasized cost-cutting measures to achieve profitability.

Philanthropy

Bancel pledged to donate all after-tax proceeds from his original Moderna stock options to charity. The donation is estimated to be worth approximately $355 million.

Career Milestones

2000

Various roles at Eli Lilly and Company

Served in various roles, including managing director for Belgium and executive director of global manufacturing strategy and supply chain.

2007

CEO of BioMérieux

Became CEO of French diagnostics company BioMérieux.

2011

CEO of Moderna

Joined Moderna as CEO.

2022

Nominated Chevalier of the Legion d'honneur

Recognized with the highest recognition in France.

2024

Elected to the U.S. National Academy of Engineering

Recognized for his contributions to engineering.

Philanthropy & Social Impact

General Philanthropy

Bancel Philanthropies

$355M

Donates to people and programs with the potential to transform lives, advance social justice, and heal communities.

Business Philosophy & Leadership

Notable Quotes

"If you surround yourself with mission-minded people, you will do great things. What were the odds that a kid from Marseille, France, sitting in the 1995 University of Minnesota graduating class, would have the opportunity to build a company like Moderna?"

"I'm always trying to get ahead of things. This is the first time we've lived through a pandemic, and we all know the consequences—from public health to mental health to economics. We're still in the middle of it, and it's going to be a very dark and hard winter. So we've got to keep working."

Leadership Principles

Relentless pursuit of innovation

Focus on innovation, the importance of platformization and digitization, and the need for an organizational culture mixing risk acceptance, unconventional disruption and willingness to learn.

Mission-driven focus

Surrounding oneself with mission-minded people to achieve great things.

Controversies & Challenges

2022

Executive Compensation Criticism

Criticism over high executive compensation at Moderna, despite taxpayer funding for vaccine development.